###begin article-title 0
###xml 66 82 66 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 66 82 <span type="species:ncbi:562">Escherichia coli</span>
Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 486 503 486 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 486 507 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Efflux pump activity has been associated with multidrug resistance phenotypes in bacteria, compromising the effectiveness of antimicrobial therapy. The development of methods for the early detection and quantification of drug transport across the bacterial cell wall is a tool essential to understand and overcome this type of drug resistance mechanism. This approach was developed to study the transport of the efflux pump substrate ethidium bromide (EtBr) across the cell envelope of Escherichia coli K-12 and derivatives, differing in the expression of their efflux systems.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 43 51 43 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 584 591 584 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 1054 1056 1052 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1082 1084 1078 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1114 1116 1108 1110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 43 55 <span type="species:ncbi:83333">E. coli K-12</span>
###xml 584 591 <span type="species:ncbi:562">E. coli</span>
EtBr transport across the cell envelope of E. coli K-12 and derivatives was analysed by a semi-automated fluorometric method. Accumulation and efflux of EtBr was studied under limiting energy supply (absence of glucose and low temperature) and in the presence and absence of the efflux pump inhibitor, chlorpromazine. The bulk fluorescence variations were also observed by single-cell flow cytometry analysis, revealing that once inside the cells, leakage of EtBr does not occur and that efflux is mediated by active transport. The importance of AcrAB-TolC, the main efflux system of E. coli, in the extrusion of EtBr was evidenced by comparing strains with different levels of AcrAB expression. An experimental model was developed to describe the transport kinetics in the three strains. The model integrates passive entry (influx) and active efflux of EtBr, and discriminates different degrees of efflux between the studied strains that vary in the activity of their efflux systems, as evident from the calculated efflux rates:  = 0.0173 +/- 0.0057 min-1;  = 0.0106 +/- 0.0033 min-1; and  = 0.0230 +/- 0.0075 min-1.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 121 129 121 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 121 128 <span type="species:ncbi:562">E. coli</span>
The combined use of a semi-automated fluorometric method and an experimental model allowed quantifying EtBr transport in E. coli strains that differ in their overall efflux activity. This methodology can be used for the early detection of differences in the drug efflux capacity in bacteria accounting for antibiotic resistance, as well as for expedite screening of new drug efflux inhibitors libraries and transport studies across the bacterial cell wall.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 280 297 280 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 528 529 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 530 531 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 663 664 663 664 <underline xmlns:xlink="http://www.w3.org/1999/xlink">A</underline>
###xml 667 668 667 668 <underline xmlns:xlink="http://www.w3.org/1999/xlink">B</underline>
###xml 675 676 675 676 <underline xmlns:xlink="http://www.w3.org/1999/xlink">C</underline>
###xml 707 708 707 708 <underline xmlns:xlink="http://www.w3.org/1999/xlink">M</underline>
###xml 713 714 713 714 <underline xmlns:xlink="http://www.w3.org/1999/xlink">F</underline>
###xml 725 726 725 726 <underline xmlns:xlink="http://www.w3.org/1999/xlink">S</underline>
###xml 748 749 748 749 <underline xmlns:xlink="http://www.w3.org/1999/xlink">R</underline>
###xml 759 760 759 760 <underline xmlns:xlink="http://www.w3.org/1999/xlink">N</underline>
###xml 775 776 775 776 <underline xmlns:xlink="http://www.w3.org/1999/xlink">D</underline>
###xml 802 803 802 803 <underline xmlns:xlink="http://www.w3.org/1999/xlink">S</underline>
###xml 808 809 808 809 <underline xmlns:xlink="http://www.w3.org/1999/xlink">M</underline>
###xml 818 819 818 819 <underline xmlns:xlink="http://www.w3.org/1999/xlink">R</underline>
###xml 850 851 850 851 <underline xmlns:xlink="http://www.w3.org/1999/xlink">M</underline>
###xml 860 861 860 861 <underline xmlns:xlink="http://www.w3.org/1999/xlink">A</underline>
###xml 864 865 864 865 <underline xmlns:xlink="http://www.w3.org/1999/xlink">T</underline>
###xml 879 880 879 880 <underline xmlns:xlink="http://www.w3.org/1999/xlink">E</underline>
###xml 904 905 904 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 906 907 906 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1077 1078 1077 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1079 1080 1079 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1086 1093 1086 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 1281 1282 1281 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1283 1284 1283 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1285 1287 1285 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1711 1713 1711 1713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1990 1991 1990 1991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1992 1994 1992 1994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1995 1997 1995 1997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 2070 2077 2070 2077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 2281 2282 2281 2282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 2283 2285 2283 2285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 2286 2288 2286 2288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 2289 2291 2289 2291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 280 296 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1086 1093 <span type="species:ncbi:562">E. coli</span>
###xml 1152 1157 <span type="species:ncbi:9606">human</span>
###xml 2070 2077 <span type="species:ncbi:562">E. coli</span>
Efflux pumps are major defensive components of the bacterial cell wall that actively extrude noxious compounds from the periplasm and/or cytoplasm, thereby decreasing their intracellular concentration [1,2]. Active efflux of antibiotics by bacteria was first described in 1978 in Escherichia coli resistant to tetracycline [3] and, since then, it has been proven that the constitutive or inductive expression of these systems is responsible for the intrinsic and acquired resistance of many bacterial species to antimicrobials [4,5]. Bacterial efflux pumps may be divided into five categories, according to their bioenergetics and structural characteristics: the ATP-Binding Cassette (ABC) superfamily, the Major Facilitator Superfamily (MFS), the Resistance Nodulation cell Division (RND) family, the Small Multidrug Resistance (SMR) family and the Multidrug And Toxic compound Extrusion (MATE) family [5-7]. Efflux pumps may be specific for one substrate or recognize a wide range of structurally dissimilar and unrelated compounds, including several classes of antibiotics [7,8]. In E. coli, the most common commensal Gram-negative bacterium of the human gut, at least nine proton dependent efflux pumps responsible for multidrug resistant (MDR) phenotypes have been described [2,9-11]. Among these, the tripartite AcrAB-TolC system is recognized as the most important multi-component efflux system and is composed of: (i) AcrB, an inner membrane protein that functions as the transporter component of the pump; (ii) TolC, the protein that traverses the cell envelope and provides a conduit to the exterior; and (iii) AcrA, two periplasmic embedded membrane proteins that anchor TolC to the plasma membrane [12]. The AcrAB-TolC system is responsible for the extrusion of substrates from the periplasm and/or the cytoplasm. The over-expression of this efflux system is a major cause of the MDR phenotype of clinical isolates, due to its ability to extrude several classes of antibiotics [2,10,13]. Although AcrAB-TolC is considered the most important efflux system of E. coli, other tripartite efflux pumps, such as the AcrEF-TolC can extrude similar substrates albeit at lower efficiency levels. Moreover, these pumps can be over-expressed when AcrAB is deleted or inactivated [8,11,13,14].
###end p 9
###begin p 10
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 850 852 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 938 941 938 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e</italic>
###xml 1016 1018 1016 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1019 1021 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Several methods have been used to detect and quantify the activity of bacterial efflux pump systems using radio-labeled, metal-labeled or fluorescent substrates to monitor their efflux in bacterial cells [15-21]. Bulk measurement techniques that use fluorescence spectroscopy yield a general understanding that represents the balance between entry and extrusion of a given substrate, which may result from the efflux activities of one or several pumps [17,19], and where cell membrane permeability also plays an important role [11,14]. Because the permeability to the substrate may be regulated by a decreased number of porins or by an increase of the lipopolysaccharide layer of the cell envelope [11,14], the demonstration of efflux activity invariably involves the use of an agent that promotes a significant increase of substrate accumulated [19,22,23]. Unless the demonstration of the role of a specific efflux pump is readily made, i.e. by the quantification of the expression level of a specific transporter [11,13], or by the use of mutants whose specific efflux pump has been deleted or inactivated [10], very little can be said about the role that any efflux pump system may play in the MDR phenotype of bacteria.
###end p 10
###begin p 11
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 870 872 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1002 1010 1002 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1202 1204 1193 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1205 1207 1196 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1301 1309 1292 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1002 1014 <span type="species:ncbi:83333">E. coli K-12</span>
Recently, a semi-automated fluorometric method has been developed by us for the assessment of efflux pump activity in bulk bacterial cells [22]. The method uses the common efflux pump substrate ethidium bromide (EtBr) that has been shown to be a particularly suitable probe for these studies. In fact it emits weak fluorescence in aqueous solution (external to the cell) and becomes strongly fluorescent when its concentration within the periplasm exceeds that of the aqueous solution due to its binding to cellular components [16]. Such binding must be of a weak type if the agent is to serve as a useful probe for efflux, since later intercalation into DNA results in strong binding that precludes any dissociation of the substrate for efflux [16,17]. This method can distinguish accumulation, which reflects the balance between influx and efflux, from efflux itself [22] and, therefore, has the potential for the study of the kinetics of EtBr transport. The method was developed using the wild-type E. coli K-12 AG100 as the bacterial model and the accumulation and efflux of EtBr was monitored by real-time fluorometry using the Rotor-Genetrade mark 3000 from Corbett Research (Sydney, Australia) [22-24]. The major innovation of this method is the simultaneous evaluation of efflux pump activity in vivo and on-line of a large number of samples, with the possibility to expose the same cell preparation to different environmental conditions in a single assay.
###end p 11
###begin p 12
###xml 183 191 183 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 305 306 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 306 308 306 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 312 313 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 313 314 313 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 183 190 <span type="species:ncbi:562">E. coli</span>
In the study to be described herein, this method has been used to define and parameterize a mechanistic experimental model that demonstrates the kinetics of EtBr influx and efflux by E. coli strains that differ in their capacity to extrude this molecule. The determination of the influx and efflux rates (k+ and k-, respectively) of a fluorescent substrate by the approach proposed allows the quantification of the cell overall efflux capacity. This information can be useful to interpret different phenotypes resulting from this efflux activity, including multidrug resistance in clinical bacterial strains.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Bacteria
###end title 14
###begin p 15
###xml 52 60 52 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 89 114 89 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">argE3 thi-l rpsL xyl mtl </italic>
###xml 120 128 116 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gal-uvrB</italic>
###xml 130 136 126 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">supE44</italic>
###xml 200 208 196 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 221 226 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">acrAB</italic>
###xml 230 234 222 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">903 </italic>
###xml 237 238 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r</sup>
###xml 332 336 324 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">903 </italic>
###xml 343 349 335 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">acrAB </italic>
###xml 357 359 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 366 374 358 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 379 382 371 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET</sub>
###xml 613 619 603 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">acrAB </italic>
###xml 699 701 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 702 704 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 707 715 697 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 870 872 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1002 1006 986 990 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET </sub>
###xml 52 64 <span type="species:ncbi:83333">E. coli K-12</span>
###xml 200 207 <span type="species:ncbi:562">E. coli</span>
###xml 366 373 <span type="species:ncbi:562">E. coli</span>
###xml 707 719 <span type="species:ncbi:83333">E. coli K-12</span>
The following bacteria were employed in this study: E. coli K-12 AG100 wild-type strain (argE3 thi-l rpsL xyl mtl Delta(gal-uvrB) supE44), containing a fully functional AcrAB-TolC efflux pump system; E. coli AG100A (DeltaacrAB::Tn903 Kanr) with the AcrAB-TolC efflux pump system inactivated due to the insertion of the transposon Tn903 in the acrAB operon [10]; and E. coli AG100TET, a AG100 progeny strain, induced to high level of resistance to tetracycline (able to survive in 10 mug/ml of tetracycline, with an MIC of 12 mug/ml), as previously described, and over-expressing several efflux pumps, among which acrAB shows the highest expression level when exposed to high levels of tetracycline [11,13]. E. coli K-12 AG100 and AG100A have been previously characterized and were kindly offered by Hiroshi Nikaido (University of California, Berkeley, California, USA) [10]. Bacterial cultures were grown in Luria-Bertani (LB) medium at 37degreesC with agitation (220 rpm). Cultures of AG100A and AG100TET were supplemented with 100 mug/ml of kanamycin and 10 mug/ml of tetracycline, respectively.
###end p 15
###begin title 16
Reagents
###end title 16
###begin p 17
Phosphate Buffered Solution (PBS), glucose, EtBr, kanamycin, ciprofloxacin, ofloxacin, chloramphenicol, erythromycin, tetracycline and chlorpromazine (CPZ) were purchased from Sigma-Aldrich Quimica SA (Madrid, Spain). EtBr solutions were stored at 4degreesC and protected from light. Tetracycline stock solution was prepared in methanol, whereas kanamycin, ciprofloxacin, ofloxacin, erythromycin and CPZ were prepared in distilled water and filtered with 0.22 mum syringe filters (Millipore Corporation, Bedford, USA). Chloramphenicol stock solution was prepared in ethanol. All working solutions were prepared in distilled water on the day of the experiment. LB medium was purchased from Difco (Detroit, Michigan, USA). Mueller-Hinton (MH) broth medium was purchased from Oxoid (Basingstoke, Hampshire, UK).
###end p 17
###begin title 18
Determination of minimum inhibitory concentrations (MICs)
###end title 18
###begin p 19
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
The MICs for EtBr, the efflux pump inhibitor (EPI) CPZ, kanamycin, ciprofloxacin, ofloxacin, chloramphenicol, erythromycin and tetracycline were determined by the broth microdilution method in 96-well microtitre plates according to the CLSI guidelines [25]. Briefly, bacterial strains were incubated overnight in 5 ml of MH broth at 37degreesC with shaking at 220 rpm. Bacterial cultures were then diluted in PBS to a McFarland 0.5 turbidity standard. Aliquots of 0.05 ml were transferred to each well of the 96-well plate that contained 0.15 ml of each compound at concentrations prepared at 2-fold serial dilutions in MH broth medium. The plates were incubated at 37degreesC and the MIC results registered after 16-18 h. The MIC was defined as the lowest concentration of compound for which no growth was observed. In order to assure that the EPI did not compromise the cellular viability, the concentrations used in the following work did not exceed 1/2 of the MIC. The MIC for tetracycline was also calculated in the presence of CPZ at 1/2 of the MIC.
###end p 19
###begin title 20
The semi-automated fluorometric method
###end title 20
###begin p 21
###xml 196 198 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 199 201 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 552 553 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
The method was carried out using the real-time thermocycler Rotor-Genetrade mark 3000 (Corbett Research, Sidney, Australia) to monitor the accumulation and extrusion of EtBr on a real-time basis [22,23]. The instrument allows the selection of the excitation and emission wavelengths that for EtBr are 530 nm band-pass and 585 nm high-pass filters, respectively. The fluorescence was acquired in cycles of 60 seconds, during the desired time interval, at the required temperature (37degreesC or 25degreesC). An explanatory diagram is provided in Figure 1.
###end p 21
###begin p 22
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Experimental flowchart of the semi-automated fluorometric method</bold>
Experimental flowchart of the semi-automated fluorometric method.
###end p 22
###begin title 23
(i) Accumulation assay
###end title 23
###begin p 24
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 84 92 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 223 226 223 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 282 284 282 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 361 365 361 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
###xml 666 674 665 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 694 698 693 697 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET </sub>
###xml 84 91 <span type="species:ncbi:562">E. coli</span>
###xml 666 678 <span type="species:ncbi:83333">E. coli K-12</span>
The accumulation of EtBr was carried out as previously described [22]. Briefly, the E. coli strains were grown in 10 ml of LB medium until they reached a mid-log phase, which corresponded to an optical density at 600 nm (OD600) of 0.6. The bacteria were then centrifuged at 16,060 xg for 3 minutes, the pellet washed twice with the same volume of PBS and the OD600 of the cellular suspension adjusted to 0.3. Glucose was added to the cellular suspension to a final concentration of 0.4% (v/v) and aliquots of 0.095 ml were transferred to 0.2 ml microtubes. EtBr was added in aliquots of 0.005 ml to obtain final concentrations that ranged from 1.0 to 6.0 mug/ml for E. coli K-12 AG100 and AG100TET and from 0.125 to 1.5 mug/ml for AG100A. The fluorescence was monitored in the Rotor-Genetrade mark 3000 at 37degreesC under the conditions described above. The effect of CPZ in the accumulation of EtBr was determined under conditions that optimize efflux (presence of glucose and incubation at 37degreesC). CPZ was used at concentrations that did not exceed 1/2 the MIC and the fluorescence was measured over a period of 60 minutes.
###end p 24
###begin title 25
(ii) Efflux assay
###end title 25
###begin p 26
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 94 102 94 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 342 344 336 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 951 954 939 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e</italic>
###xml 94 101 <span type="species:ncbi:562">E. coli</span>
The assessment of the efflux of EtBr was conducted as previously described [22]. Briefly, the E. coli strains were loaded with EtBr under conditions that favor accumulation (no glucose, 25degreesC and presence of CPZ). When the maximum level of EtBr accumulation was reached (approximately 60 minutes), the bacteria were centrifuged (16,060 xg for 3 minutes) and the medium was replaced by: i) PBS without glucose; ii) PBS containing glucose; and iii) PBS without glucose and with CPZ (control of minimum efflux). Aliquots of 0.1 ml were transferred to 0.2 ml microtubes and the assay was performed at 37degreesC with continuous measurement of fluorescence as described above. The efflux of EtBr is presented in terms of relative fluorescence, which is obtained from the comparison between the fluorescence observed for the bacteria in the presence or absence of glucose and the control in which the cells are exposed to conditions of minimum efflux (i.e., absence of glucose and presence of CPZ). Each experiment was conducted in triplicate and the results obtained did not vary.
###end p 26
###begin title 27
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 33 40 <span type="species:ncbi:562">E. coli</span>
Model to quantify EtBr efflux in E. coli
###end title 27
###begin title 28
(i) Quantification of intracellular EtBr concentration
###end title 28
###begin p 29
###xml 236 237 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o</sub>
###xml 317 324 316 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">intial </italic>
###xml 317 324 316 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>intial </italic></sub>
###xml 337 339 336 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0 </sub>
###xml 643 645 642 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 862 880 851 869 <sub xmlns:xlink="http://www.w3.org/1999/xlink">filt non corrected</sub>
In order to assess the amount of EtBr extruded from the cells, one has to quantify the amount retained inside the cells. First, a calibration curve is determined that correlates the initial fluorescence of the buffer containing EtBr (FLo) with the corresponding EtBr concentration (varying from 0 to 6 mug/ml): [EtBr]intial = 0.1201 x FL0 + 0.0373(R = 0.99). Then, for each concentration tested, an EtBr accumulation assay was performed, as described above. To quantify the intracellular EtBr concentration, at the end of the accumulation assay, 0.6 ml of each EtBr containing buffer were separated from the cells by centrifugation at 16,060 xg for 10 minutes and the supernatant filtered with 0.22 mum syringe filters from Millipore Corporation (Bedford, USA). The fluorescence of the cell free buffer was measured in the Rotor-Genetrade mark 3000 (FL(PBS+EtBr)filt non corrected).
###end p 29
###begin p 30
###xml 199 213 199 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink">filt corrected</sub>
###xml 240 258 240 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink">filt non corrected</sub>
###xml 363 364 363 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o</sub>
###xml 383 398 383 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink">filt corrected </sub>
###xml 815 827 815 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink">int exp corr</sub>
###xml 925 937 925 937 <sub xmlns:xlink="http://www.w3.org/1999/xlink">int exp corr</sub>
###xml 1017 1021 1017 1021 <sub xmlns:xlink="http://www.w3.org/1999/xlink">int </sub>
###xml 1033 1045 1033 1045 <sub xmlns:xlink="http://www.w3.org/1999/xlink">int exp corr</sub>
###xml 1251 1259 1251 1259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1366 1369 1366 1369 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET</sub>
###xml 1251 1263 <span type="species:ncbi:83333">E. coli K-12</span>
Since some EtBr is retained by the filter itself, a correction factor must be used to account for this difference. Thus, the corrected fluorescence of the filtered buffer corresponds to (FL(PBS+EtBr)filt corrected). = 1.2289 x (FL(PBS+EtBr)filt non corrected). + 0.7032 (R = 0.99). The difference between the initial fluorescence of the EtBr containing buffer (FLo) and (FL(PBS+EtBr)filt corrected gives the fluorescence corresponding to the intracellular EtBr concentration. However, the fluorescence data from the transport assays measured experimentally still contains a component from the EtBr that remains in solution. Thus, each value of the experimental accumulation curve can then be corrected by subtracting the background corresponding to the fluorescence of the initial EtBr concentration, originating FLint exp corr. By plotting the previously determined EtBr intracellular concentration for the final value of FLint exp corr, for each initial EtBr concentration tested, a new relation is achieved: [EtBr]int = 0.022 x FLint exp corr+ 0.06 (R = 0.99), which allows the conversion of the experimental fluorescence data over time into intracellular EtBr concentration over time. The correlations shown here were determined for the wild-type E. coli K-12 AG100. Similar relations were determined specifically for the other two strains used (AG100A and AG100TET).
###end p 30
###begin title 31
(ii) Mathematical and statistical analyses
###end title 31
###begin p 32
###xml 55 59 55 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink">int </sub>
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 62 63 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 84 95 84 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Table Curve</italic>
###xml 264 265 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 265 267 256 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 271 272 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 272 273 263 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
The model was fitted to the experimental values ([EtBr]int vs t) using the software Table Curvetrade mark 2D from Jandel Scientific - AISN Software STATISTICA, which allowed the determination of the values of the parameters describing the influx and efflux rates, k+ and k-, respectively. Three independent assays were conducted and the results shown are the average +/- standard deviation. P-value from the ANOVA statistical test was calculated.
###end p 32
###begin title 33
(iii) Model validation
###end title 33
###begin p 34
###xml 94 102 94 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 130 134 130 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET </sub>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 263 265 263 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 269 270 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 270 272 270 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 94 106 <span type="species:ncbi:83333">E. coli K-12</span>
The predictive model proposed was validated by comparing the experimental data obtained using E. coli K-12 AG100, AG100A and AG100TET cell suspensions incubated in the presence of different concentrations of EtBr and the curves generated by the model, using the k+ and k- constants determined as described above.
###end p 34
###begin title 35
Flow cytometry
###end title 35
###begin p 36
This methodology was used to corroborate the analysis of the data obtained with the semi-automated fluorometric method. Therefore, the samples from the accumulation and efflux assays, used in the semi-automated fluorometric method, were also analyzed by flow cytometry, in order to compare the results obtained with these two methodologies. Data acquisition and analysis were performed using a FACSCaliburtrade mark (BD Biosciences, San Jose, CA, USA). EtBr was excited at 488 nm and the fluorescence detected through a 585 nm filter (FL-2 channel).
###end p 36
###begin title 37
(i) Accumulation assay
###end title 37
###begin p 38
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 89 93 83 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
###xml 148 150 142 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 235 239 229 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
###xml 0 7 <span type="species:ncbi:562">E. coli</span>
E. coli strains were cultured in 10 ml of LB medium at 37degreesC and 220 rpm until an OD600 of 0.6. Aliquots of 1.0 ml were centrifuged at 16,060 xg for 3 minutes, the supernatant discarded and the pellet washed twice with PBS. The OD600 of the bacterial suspension was adjusted to 0.3 using PBS without glucose. EtBr was added at a final concentration of 1 mug/ml and CPZ was added to a final concentration of 20 mug/ml. Following incubation at 25degreesC for 60 minutes, aliquots of 0.5 ml were taken for fluorescence measurement in the flow cytometer FACSCaliburtrade mark. Data was collected for at least 10,000 events per sample.
###end p 38
###begin title 39
(ii) Efflux assay
###end title 39
###begin p 40
###xml 136 138 134 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 242 246 240 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
After loading the bacteria with EtBr (1 mug/ml) in the presence of CPZ (20 mug/ml), the bacterial suspension was centrifuged at 16,060 xg for 3 minutes. The supernatant was removed and the pellet resuspended in EtBr-free PBS, adjusting the OD600 to 0.3. Efflux was assessed in the presence and absence of glucose at 0.4% (v/v). Aliquots of 0.5 ml were taken after 2.5, 5, 15, 30 and 60 minutes after incubation at 37degreesC, for fluorescence measurement in the flow cytometer FACSCaliburtrade mark. Analyses were performed with an acquisition of at least 10,000 events per sample.
###end p 40
###begin title 41
Results and Discussion
###end title 41
###begin title 42
###xml 34 42 34 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 34 41 <span type="species:ncbi:562">E. coli</span>
Detecting EtBr efflux mediated by E. coli efflux pump systems
###end title 42
###begin p 43
###xml 105 108 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e</italic>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 252 260 252 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 528 531 528 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e</italic>
###xml 660 668 653 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 687 689 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 721 727 713 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">acrAB </italic>
###xml 747 749 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 780 783 771 774 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET</sub>
###xml 784 790 775 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">acrAB </italic>
###xml 841 843 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 909 912 900 903 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET</sub>
###xml 252 259 <span type="species:ncbi:562">E. coli</span>
###xml 660 672 <span type="species:ncbi:83333">E. coli K-12</span>
Experiments were carried out with EtBr concentrations that did not affect in any way the cell viability, i.e., that did not exceed 1/2 the MIC for EtBr (Table 1). In this case and as previously demonstrated, accumulation of EtBr and its extrusion from E. coli are the result of the balance between EtBr entry by passive diffusion (influx) and the extrusion activity of efflux pump systems, primarily the AcrAB-TolC [11,13]. As shown by Figure 2, the accumulation of EtBr under conditions that are considered to maximize efflux, i.e., presence of glucose and 37degreesC, begins to take place at a concentration of EtBr that exceeds 1.0 mug/ml for the wild-type E. coli K-12 AG100 (Figure 2A), 0.250 mug/ml for the AG100A (acrAB inactivated; Figure 2B), and 1.0 mug/ml for the AG100TET(acrAB and other efflux pump genes over-expressed; Figure 2C). As expected, the strain that over-express efflux systems (AG100TET) accumulates the least amount of EtBr even when the maximum concentration of EtBr to which it is exposed is 6 mug/ml. On the contrary, the AG100A, whose AcrAB efflux pump has been inactivated, accumulates approximately 25 times more EtBr when exposed to a far lower concentration of 1.5 mug/ml of EtBr. The importance of the AcrAB-TolC efflux system is further illustrated by the comparison of accumulation of EtBr by the wild-type AG100 to that by the AG100A, when both strains are exposed to 1 mug/ml of EtBr.
###end p 43
###begin p 44
###xml 47 55 47 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 78 81 78 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET</sub>
###xml 47 54 <span type="species:ncbi:562">E. coli</span>
MIC values of EtBr and several antibiotics for E. coli AG100, AG100A and AG100TET.
###end p 44
###begin p 45
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">903 </italic>
###xml 232 240 232 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 253 258 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">acrAB</italic>
###xml 262 266 258 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">903 </italic>
###xml 269 270 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r</sup>
###xml 393 396 386 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET</sub>
###xml 232 239 <span type="species:ncbi:562">E. coli</span>
Ethidium Bromide (EtBr); Kanamycin (KAN); Ciprofloxacin (CIP); Ofloxacin (OFX); Chloramphenicol (CHL); Erythromycin (ERY); Tetracycline (TET); and Chlorpromazine (CPZ). Kanamycin was included as control for the presence of Tn903 in E. coli AG100A (DeltaacrAB::Tn903 Kanr). The tetracycline MICs were also calculated in the presence of 30 mug/ml (AG100), 10 mug/ml (AG100A) and 70 mug/ml (AG100TET) of CPZ (1/2 CPZ MIC).
###end p 45
###begin p 46
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 97 101 97 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET </sub>
###xml 0 104 0 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Accumulation of EtBr at increasing concentrations by <italic>E. coli </italic>K-12 AG100 (A), AG100A (B) and AG100<sub>TET </sub>(C)</bold>
###xml 211 215 205 209 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Note</bold>
###xml 53 65 <span type="species:ncbi:83333">E. coli K-12</span>
Accumulation of EtBr at increasing concentrations by E. coli K-12 AG100 (A), AG100A (B) and AG100TET (C). The bacteria were exposed to increasing concentrations of EtBr at 37degreesC in the presence of glucose. Note: assays for AG100A were carried out with lowest EtBr concentrations (0.125 mug/ml - 1.5 mug/ml) -- see text.
###end p 46
###begin p 47
###xml 115 118 115 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g</italic>
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 540 548 540 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 774 778 774 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET </sub>
###xml 866 874 866 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 964 966 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 540 552 <span type="species:ncbi:83333">E. coli K-12</span>
###xml 866 878 <span type="species:ncbi:83333">E. coli K-12</span>
Accumulation of EtBr inside the bacterial cells can be increased in the presence of an EPI such as phenothiazines (e.g. CPZ), compounds that have been shown to inhibit efflux activity of Gram-negative bacteria [4,5,22]. Thus, these compounds are usually employed for the demonstration of over-expressed efflux pumps of bacteria [5,19,22,23]. Because of the real-time capacity and sensitivity of the semi-automated fluorometric method, the demonstration of the effects of an EPI, such as CPZ, on the intrinsic efflux system of the wild-type E. coli K-12 AG100 is readily made. As shown by Figure 3A (A1 and A2), high concentrations of CPZ maximize the amount of EtBr accumulated only when glucose is absent from the medium. Similar results were obtained for the strains AG100TET and AG100A (data not shown). The effect of CPZ on the accumulation of EtBr by wild-type E. coli K-12 AG100 is similarly demonstrated and confirmed with the aid of flow cytometry (Figure 3B).
###end p 47
###begin p 48
###xml 55 63 55 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of chlorpromazine (CPZ) on EtBr accumulation by <italic>E. coli </italic>K-12 AG100</bold>
###xml 442 445 435 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nd </sup>
###xml 455 463 448 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 55 67 <span type="species:ncbi:83333">E. coli K-12</span>
###xml 455 467 <span type="species:ncbi:83333">E. coli K-12</span>
Effect of chlorpromazine (CPZ) on EtBr accumulation by E. coli K-12 AG100. The bacteria were loaded with EtBr at 1 mug/ml in the presence of increasing concentrations of CPZ for a period of 60 minutes at 37degreesC in the presence and absence of glucose and accumulation assessed by: (A1 and A2) the semi-automated fluorometric method; (B) flow cytometry, represented by an histogram overlay corresponding to the data selected for analysis (2nd gate) for E. coli K-12 AG100 (i) without EtBr or CPZ, (ii) after 60 minutes of exposure to EtBr (1 mug/ml) and (iii) after 60 minutes of exposure to EtBr (1 mug/ml) and CPZ (20 mug/ml) at 37degreesC without glucose. Data in graphics A1 and A2 correspond to the same assay and were separated for the sake of figure clarity.
###end p 48
###begin p 49
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 704 705 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 846 854 833 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 846 853 <span type="species:ncbi:562">E. coli</span>
The on-line visualization of efflux activity by the EtBr loaded cells requires that accumulation of EtBr has previously taken place. Therefore, before performing the efflux assays, bacteria are exposed to conditions that promote significant accumulation of EtBr [22,23]. To this extent, we have chosen a temperature of 25degreesC, absence of glucose and presence of CPZ (20 mug/ml), to promote maximum accumulation, within 60 minutes. When maximum accumulation has taken place under these conditions, the bacteria are washed free of EtBr and CPZ, and resuspended in fresh buffer with and without glucose. Fluorescence readings were conducted over a period of 15 minutes at 37degreesC. As shown by Figure 4, restoration of optimum conditions of glucose, noted to prevent accumulation, are required for the extrusion of EtBr. This assay shows that E. coli cells need an energy source for efflux to take place.
###end p 49
###begin p 50
###xml 28 36 28 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Detection of EtBr efflux in <italic>E. coli </italic>K-12 AG100</bold>
###xml 465 468 451 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nd </sup>
###xml 478 486 464 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 28 40 <span type="species:ncbi:83333">E. coli K-12</span>
###xml 478 490 <span type="species:ncbi:83333">E. coli K-12</span>
Detection of EtBr efflux in E. coli K-12 AG100. The bacteria were loaded with EtBr at 1 mug/ml in the presence of CPZ (20 mug/ml) for a period of 60 minutes at 25degreesC. After replacing the buffer with EtBr-free PBS with or without glucose, the efflux was assessed by: (A) the semi-automated fluorometric method, performed at 37degreesC for 15 minutes; and (B) flow cytometry, represented by an histogram overlay corresponding to the data selected for analysis (2nd gate) for E. coli K-12 AG100 immediately after replacing the buffer with EtBr-free PBS (t = 0) and 15 minutes after incubation at 37degreesC with or without glucose.
###end p 50
###begin p 51
###xml 112 120 112 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 112 119 <span type="species:ncbi:562">E. coli</span>
Therefore, this methodological approach proved its usefulness for the demonstration of active efflux of EtBr in E. coli and the strategy developed allowed to differentiate influx (passive diffusion into the cell) from efflux activity (active efflux through pumps).
###end p 51
###begin title 52
###xml 31 39 31 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 31 38 <span type="species:ncbi:562">E. coli</span>
Modeling EtBr transport across E. coli cell wall
###end title 52
###begin p 53
In order to quantify the efflux activity, a mechanistic experimental model that establishes a balance related to the intracellular EtBr concentration was developed, as described below:
###end p 53
###begin p 54

###end p 54
###begin p 55
###xml 12 16 12 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink">int </sub>
###xml 72 76 71 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ext </sub>
###xml 122 124 120 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 169 171 167 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 178 180 176 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 238 240 236 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
where [EtBr]int is the intracellular EtBr concentration (mug/ml); [EtBr]ext is the external EtBr concentration (mug/ml); k+ is the rate of EtBr entry into the cells (min-1) and k- corresponds to the rate of EtBr efflux from the cells (min-1). Therefore,
###end p 55
###begin p 56

###end p 56
###begin p 57
###xml 12 16 12 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Tot </sub>
###xml 126 129 125 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink">int</sub>
###xml 239 246 238 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 239 246 <span type="species:ncbi:562">E. coli</span>
where [EtBr]Tot is the total EtBr concentration (mug/ml). Replacing equation (1.2) in equation (1.1) and solving it for [EtBr]int, it is possible to obtain the following equation, which describes the EtBr transport across the cell wall of E. coli:
###end p 57
###begin p 58

###end p 58
###begin p 59
###xml 208 216 208 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 248 251 248 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET</sub>
###xml 622 624 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 625 627 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 746 747 736 737 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 874 876 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 208 215 <span type="species:ncbi:562">E. coli</span>
The equation developed herein (eq. 1.3) allied to the technical approach used to quantify the intracellular EtBr concentration (Methods) allowed us to quantify the degree of EtBr efflux activity in the three E. coli strains (AG100, AG100A and AG100TET). This strategy is based on the distinct levels of EtBr fluorescence in solution and inside the cells. EtBr emits fluorescence when it is free in solution (in this case, PBS) in a concentration dependent manner, accurately captured by the photomultiplier detector with the 585 nm high-pass filter of the Rotor-Genetrade mark 3000 that differentiates mug/ml differences [22,24]. The high sensitivity of this detector ensue the definition of a calibration curve, which correlates fluorescence (FL0) and the initial EtBr concentration in solution, before the cells are added to the medium, varying from 0 mug/ml to 6 mug/ml [24]:
###end p 59
###begin p 60

###end p 60
###begin p 61
###xml 12 22 12 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">initial = </sub>
###xml 28 33 28 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Total</sub>
###xml 44 52 44 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 130 133 129 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET</sub>
###xml 341 342 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 572 574 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 575 577 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 882 884 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 885 887 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 888 890 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 891 893 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 44 51 <span type="species:ncbi:562">E. coli</span>
where [EtBr]initial = [EtBr]Total. When the E. coli cells are exposed to EtBr containing buffer (1 to 6 mug/ml for AG100 and AG100TET; 0.125 to 1.5 mug/ml for AG100A), the cells start to accumulate EtBr that enters by passive diffusion, with the efflux pump systems trying to balance this entry according to the kinetics presented in Figure 2. At these low concentrations, EtBr does not reach the cellular components in the cytoplasm to which it could bind irreversibly, being effluxed from the cytoplasm and periplasm by either single- or multi-component efflux systems [26,27]. When the concentration of EtBr within the periplasmic space exceeds significantly its extrusion, EtBr is translocated beyond the inner plasma membrane where the medial sites of the cell contain nucleic acids to which the EtBr can intercalate almost irreversibly, after which extrusion is not possible [16,17,26,27].
###end p 61
###begin p 62
###xml 215 219 215 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink">int </sub>
###xml 231 244 231 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink">int exp corr </sub>
###xml 299 310 299 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Table Curve</italic>
###xml 494 496 485 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 501 502 492 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 629 630 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 639 640 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 667 669 658 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 674 676 665 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 775 783 766 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 775 782 <span type="species:ncbi:562">E. coli</span>
Using the rationale described in Methods, it is possible to correlate the fluorescence readings by the semi-automated fluorometric method in bulk cells to the EtBr concentration that remains inside the cells; [EtBr]int = 0.022 x FLint exp corr + 0.06 (R = 0.99). With the assistance of the software Table Curvetrade mark 2D from Jandel Scientific - AISN Software STATISTICA, it is then possible to adjust the model (eq. 1.3.) to the experimental data and determine the values of the constants k+ and k-, which represent a measure of the rate of entry and the rate of efflux of EtBr into and out of the cell, respectively (Figure 5). Table 2 summarizes the values of k+ and k- obtained for the three strains tested. The values obtained show similar influx rates for the three E. coli strains studied, as expected, since this parameter reflects the entry of EtBr by passive diffusion. Both the passive influx absolute values and their variation among the three strains are negligible when compared to the values obtained for the efflux rates.
###end p 62
###begin p 63
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 38 46 38 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 74 77 74 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET</sub>
###xml 38 50 <span type="species:ncbi:83333">E. coli K-12</span>
Influx (k+) and efflux (k-) rates for E. coli K-12 AG100, AG100A and AG100TET.
###end p 63
###begin p 64
###xml 1 3 1 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 8 10 8 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
k+ and k- were determined using the software Table Curvetrade mark 2D from Jandel Scientific - AISN Software STATISTICA to adjust the model (eq. 1.3.) to the experimental data obtained with the semi-automated fluorometric method (Figure 2). The results represent an average of three independent assays with the correspondent standard deviation.
###end p 64
###begin p 65
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 49 57 49 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Influx (k<sup>+</sup>) and efflux (k<sup>-</sup>) rates of EtBr in the <italic>E. coli </italic>strains tested</bold>
###xml 191 199 191 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 238 241 238 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET</sub>
###xml 49 56 <span type="species:ncbi:562">E. coli</span>
###xml 191 198 <span type="species:ncbi:562">E. coli</span>
Influx (k+) and efflux (k-) rates of EtBr in the E. coli strains tested. The values shown represent averages of three independent experiments and respective standard deviations for the three E. coli strains tested: AG100, AG100A and AG100TET.
###end p 65
###begin p 66
###xml 274 278 274 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET </sub>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
The model proposed accurately describes the behavior of the three strains, showing a lower efflux rate for the AG100A strain when compared to the wild-type AG100 (P value = 0.0023), as a result of the inactivation of the AcrAB-TolC system in the mutant strain. For the AG100TET strain the model revealed a significantly increased efflux rate compared to the wild-type strain (P value = 0.0057). This result reflects the higher efflux activity in this tetracycline adapted strain due to the over-expression of efflux pumps, particularly of the AcrAB-TolC system [11,13].
###end p 66
###begin p 67
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 179 187 179 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 197 202 197 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EtBr </sub>
###xml 270 272 267 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 300 308 297 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 319 324 316 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink">EtBr </sub>
###xml 393 395 387 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 442 450 436 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 455 458 449 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET</sub>
###xml 550 552 542 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 782 783 773 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1090 1091 1081 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 179 186 <span type="species:ncbi:562">E. coli</span>
###xml 300 307 <span type="species:ncbi:562">E. coli</span>
###xml 442 449 <span type="species:ncbi:562">E. coli</span>
Moreover, the results provided by the model, in terms of EtBr efflux rates, correlate with the MIC for EtBr for each of the strains studied (Table 1). While the wild-type strain, E. coli AG100 (MICEtBr = 150 mug/ml), showed a EtBr efflux rate of  = 0.0173 +/- 0.0057 min-1, the AcrAB deleted strain, E. coli AG100A (MICEtBr = 5 mug/ml), had the lowest EtBr efflux rate  = 0.0106 +/- 0.0033 min-1. Conversely, the tetracycline induced strain, E. coli AG100TET, over-expressing the AcrAB system, shows a much higher efflux rate  = 0.0230 +/- 0.0075 min-1, which corresponds to an MIC for EtBr of 300 mug/ml. MICs of each strain towards several antibiotics known to be efflux pump substrates also showed a correlation between efflux activity and resistance level to these drugs (Table 1). The determination of the MICs for tetracycline in the presence of the EPI CPZ reinforced the role played by efflux on such resistance, as the MICs values decreased in the presence of sub-inhibitory concentrations of this EPI, according to the efflux activity previously determined for each strain (Table 1).
###end p 67
###begin p 68
###xml 118 120 118 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 132 140 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 252 260 252 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 448 456 448 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 132 139 <span type="species:ncbi:562">E. coli</span>
###xml 252 259 <span type="species:ncbi:562">E. coli</span>
###xml 448 455 <span type="species:ncbi:562">E. coli</span>
This approach allowed us, for the first time in the literature, to calculate the values of EtBr influx/efflux rates (k+ and k-) for E. coli and to construct a predictive model for the accumulation curve of this molecule at any concentration by a given E. coli strain, provided that EtBr concentration does not affect the cellular viability. An example of such calculation is provided in Figure 6, for three different concentrations of EtBr for the E. coli strains used. When these predictive curves are compared to the experimental data a close fit is obtained (Figure 6), thus validating the proposed model.
###end p 68
###begin p 69
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Examples of model fitting to experimental data</bold>
###xml 179 187 179 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 218 221 218 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">TET</sub>
###xml 179 186 <span type="species:ncbi:562">E. coli</span>
Examples of model fitting to experimental data. The figures represent the fitting of the model to the experimental data for the time course of intracellular EtBr concentration in E. coli strains AG100, AG100A and AG100TET, incubated in the presence of different EtBr concentrations. In each case, the solid line represents the model fit.
###end p 69
###begin title 70
Conclusion
###end title 70
###begin p 71
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 215 222 215 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 275 283 275 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 472 474 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 821 823 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 215 222 <span type="species:ncbi:562">E. coli</span>
In this work we have applied the technical advantages of the semi-automated fluorometric method [22] for the development and application of an experimental model to describe and quantify the efflux pump activity in E. coli. The semi-automated fluorometric method affords the in vivo and on-line evaluation of the efflux pump activity by real-time fluorometry using the Rotor-Genetrade mark 3000, and represents an innovative technique when compared to other technologies [23]. Based upon the differences of fluorescence that reflect differences on the EtBr concentrations outside and inside the cells, the technique provides a powerful tool for the real-time monitoring of efflux kinetics in bacterial cells. Moreover, it has potential for the identification of new efflux pump substrates, as well as new bacterial EPIs [23]. A more fundamental application is the extension of this methodology to understand the transport kinetics of EtBr or other fluorescent substrates in bacterial cells.
###end p 71
###begin p 72
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 70 77 <span type="species:ncbi:562">E. coli</span>
We used such approach to differentiate and quantify EtBr transport in E. coli, and an experimental model was developed which parameterizes passive entry (influx) and active efflux of EtBr. The methodology developed allowed to detect differences in the EtBr efflux activity among strains that differ in their efflux pump expression, highlighting the importance of these systems in the extrusion from the cell of toxic compounds such as EtBr [6,7,10].
###end p 72
###begin p 73
###xml 230 238 230 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1550 1552 1550 1552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 230 237 <span type="species:ncbi:562">E. coli</span>
Although the experimental model presented was designed based upon a set of three canonic, isogenic strains, as a way to assess the method's sensitivity to differentiate their singular efflux activities, it can be applied to other E. coli strains or bacteria, since it is based on the overall transport of EtBr across the bacterial cell wall, which is common among bacteria [2,7,16,22,23]. It should be stressed however that it allows measuring the overall efflux activity rather than efflux related to a specific pump. For evaluation of the role played by a pump, a mutant specific for that pump must be used. The determination of influx and efflux rates for each of the strains to be analyzed opens new insights and opportunities for exploration of cell wall permeability, as well as for the control of the efflux activity in bacterial cells, representing a quantitative method to determine efflux activity. This approach may be used to elaborate a standardized data base for different reference strains relative to efflux activity (efflux rates), providing the means by which one can evaluate the resistance due to efflux pump activity in standardized conditions between laboratories. It represents a particularly suitable procedure for the assessment of efflux pump activity in MDR clinical isolates and screening for potential inhibitors of such activity. Such approaches may contribute to a better understanding of the bacterial efflux systems as a resistance mechanism and to design new therapeutic strategies against MDR bacterial infections [28].
###end p 73
###begin title 74
Competing interests
###end title 74
###begin p 75
The authors declare that they have no competing interests.
###end p 75
###begin title 76
Authors' contributions
###end title 76
###begin p 77
LP and LR carried out the experimental work related to accumulation and efflux assays and MIC determination. LP and IC participated in the development of the model and LR assisted in the flow cytometry experiments. LP, LR and IC assisted in the preparation of the manuscript. MM carried out the flow cytometry experiments. PF and CCCRC participated in the development and validation of the experimental model and assisted in the preparation of the manuscript. GAM and LA assisted in the design of the study. LA assisted in the preparation of the manuscript. FS assisted in the design and performance of the flow cytometry experiments. MV conceived the study, its design and coordination and prepared the draft of the manuscript.
###end p 77
###begin p 78
All authors read and approved the final manuscript.
###end p 78
###begin title 79
Acknowledgements
###end title 79
###begin p 80
This work was supported by grants EU-FSE/FEDER-POCI/SAU-MMO/59370/2004, EU-FSE/FEDER-PTDC/BIA-MIC/71280/2006 and PTDC/BIA-MIC/105509/2008 provided by Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal. M. Martins and L. Rodrigues were supported by grants SFRH/BD/14319/2003 and SFRH/BD/24931/2005 (FCT, Portugal), respectively. C.C.C.R. de Carvalho and P. Fernandes acknowledge FCT for contract under Programme Ciencia 2007.
###end p 80
###begin article-title 81
Efflux-mediated drug resistance in bacteria
###end article-title 81
###begin article-title 82
Multidrug-resistance efflux pumps - not just for resistance
###end article-title 82
###begin article-title 83
Plasmid-determined tetracycline resistance involves new transport systems for tetracycline
###end article-title 83
###begin article-title 84
Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux
###end article-title 84
###begin article-title 85
Inhibitors of efflux pumps in Gram-negative bacteria
###end article-title 85
###begin article-title 86
###xml 54 60 <span type="species:ncbi:9606">humans</span>
Waltzing transporters and 'the dance macabre' between humans and bacteria
###end article-title 86
###begin article-title 87
Efflux pumps as antimicrobial resistance mechanisms
###end article-title 87
###begin article-title 88
Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria
###end article-title 88
###begin article-title 89
Regulation of efflux pumps in Enterobacteriaceae: genetic and chemical effectors
###end article-title 89
###begin article-title 90
###xml 79 96 79 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 79 95 <span type="species:ncbi:562">Escherichia coli</span>
AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants
###end article-title 90
###begin article-title 91
###xml 64 71 64 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 64 71 <span type="species:ncbi:562">E. coli</span>
Antibiotic Stress, Genetic Response and Altered Permeability of E. coli
###end article-title 91
###begin article-title 92
Structure and mechanism of drug efflux machinery in Gram negative bacteria
###end article-title 92
###begin article-title 93
###xml 54 71 54 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 54 75 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of proton gradient-dependent multidrug efflux pump genes
###end article-title 93
###begin article-title 94
Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens
###end article-title 94
###begin article-title 95
Single molecule techniques for biomedicine and pharmacology
###end article-title 95
###begin article-title 96
###xml 12 29 12 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 12 28 <span type="species:ncbi:562">Escherichia coli</span>
Staining of Escherichia coli for flow cytometry: influx and efflux of ethidium bromide
###end article-title 96
###begin article-title 97
Use of fluorescent probes to assess physiological functions of bacteria at single-cell level
###end article-title 97
###begin article-title 98
Using nanopartical optics assay for direct observation of the function of antimicrobial agents in single live bacterial cells
###end article-title 98
###begin article-title 99
Practical applications and feasibility of efflux pump inhibitors in the clinic - a vision for applied use
###end article-title 99
###begin article-title 100
An instrument-free method for the demonstration of efflux pump activity of bacteria
###end article-title 100
###begin article-title 101
###xml 97 120 97 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas aeruginosa </italic>
###xml 124 145 124 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 97 119 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 124 145 <span type="species:ncbi:1280">Staphylococcus aureus</span>
A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus
###end article-title 101
###begin article-title 102
###xml 46 63 46 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 46 67 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method
###end article-title 102
###begin article-title 103
New methods for the identification of efflux mediated MDR bacteria, genetic assessment of regulators and efflux pump constituents, characterization of efflux systems and screening for inhibitors of efflux pumps
###end article-title 103
###begin article-title 104
Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance
###end article-title 104
###begin article-title 105
The AcrB efflux pump: conformational cycling and peristalsis lead to multidrug resistance
###end article-title 105
###begin article-title 106
Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities
###end article-title 106

